Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride, a drug that prevents testosterone conversion, can effectively reduce blood loss in prostate surgery, especially for patients with a prostatic volume over 30 cc, and decrease post-surgery complications.

All treatments helped with prostate symptoms, but the combination of dibenyline and finasteride worked best without extra side effects.

Male pattern baldness may be an early sign of noncancerous prostate enlargement.

Certain drugs that block specific enzymes can help treat prostate diseases.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

A new score can help predict which patients might have trouble urinating after prostate surgery.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Suppressing certain hormones might help prevent prostate cancer.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

A new compound was effective for imaging prostate cancer in rats.

Finasteride treats hair loss but may affect prostate cancer detection.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Gene variation affects prostate issues and hair loss.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.